skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter and Group. On july 18/14 Bioniche Life Sciences (BNC) received written approval from the FDA to allow it to submit a BLA for marketing approval of it's drug MCNA based on it's current clinical trial data set. This would seem to be important news. What is your current opinion on the company. Thanks
Read Answer Asked by John on July 25, 2014
Q: Dear 5i
LGT recently had a 2 for 1 stock split . Can you tell me approximately what price was the stock pre split and what was the starting price of the stock after the split . Other than the stock split which would acct for the large price drop was there any other reason for the large drop in price ?
Thanks
Bill
Read Answer Asked by Bill on July 24, 2014
Q: I purchased some shares of Martin Rea (MRE) some time ago then purchased about 80% more when there began issues with the Board. My shares are now up by about 60% reflecting, I believe, the resolution of the fight within the Board. When I compare MRE to Magna, I see that MRE is essentially flat over the past year whereas MGA is up about 50%. Since the 50% for Magna is reflected to some degree in its higher PE ratio than MartinRea’s, is it reasonable to expect that MRE still has some opportunities to increase in value at a faster pace than Magna? I have no plans to sell my MRE because of the potential catchup of PE ratio unless you feel that I should be exchanging the MRE for Magna recognizing the quality of Magna versus MRE. My percentage of MRE is only about 2-3% of my entire portfolio. At this time in the auto business cycle would you recommend me increasing the percentage to the 5% range or stay cautious. If you recommend I should buy more again which of the two (or others?) would you recommend? As always, I highly respect your opinion and recommendations even if I don’t always follow them.
Read Answer Asked by ED on July 23, 2014
Q: I would appreciate your comments on Espial Group's (ESP) earnings released this morning. They seem very good to me and I am considering adding to my current small holding. Thank you, Peter
Read Answer Asked by Peter on July 23, 2014
Q: re: ET Evertz

Your updated analysis please since your last comment June 12 and... any additional insights into a possible take over?

Thanks for all you do

Gord
Read Answer Asked by Gord on July 23, 2014
Q: Hi Peter and staff,
Thanks for all the sensible advice. Shortly after 2 PM today ET took a plunge. I see no news.
Thanks for any input you may have.

John
Read Answer Asked by John on July 22, 2014
Q: Knight Therapeutics (GUD) Could I have your thoughts on GUD as it seems to be in a steady decline recently. Thanks
Read Answer Asked by Bruce on July 19, 2014
Q: Hi team,

As they have both been knocked down with this correction in energy stocks. Which do think is the better buy long term, BXE or RMP?
QST is also on my list is that now at a good price to take a full position.

Thanks Peter
Read Answer Asked by Peter on July 19, 2014
Q: Two stocks I came across and bought by reading questions and answers on your 5i site were PTS and CHN. I asked 5i about PTS awhile back and your answer was it was a long term play. I should have asked what entry point you would go with because I paid a lot more money than what it is today. CHN is down more than it is up. Waiting for your reply.

Dennis
Read Answer Asked by Dennis on July 19, 2014
Q: dcf.to
Can you please give your opinion on DCF's July 17th news release. It has been very difficult to hold this stock.
Read Answer Asked by cathy on July 18, 2014
Q: Western Forest Products, WEF. Whatdo you think of this Co. It has instituted dividend. Looks to be doing very well. I heard that there is a slow market period currently. I had 1000 shares, which I sold as the stock moved up in price. I want to buy, but looking for a bottom. Is this the bottom, or will it fall further. Any idea about the seasonality.I value your opinion a lot. Thanks.
Read Answer Asked by Vinod on July 16, 2014
Q: can you comment on XSR results just out. Revenue growth looks good and lower debt costs helpful. Is this a decent entry point for income/growth investors? thanks
Read Answer Asked by Scott on July 16, 2014
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!